Syndax Pharmaceuticals Inc
SNDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395937
In the last 90 days, Syndax Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 242 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Syndax Pharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 160
- +22 vs. Q3 2022
- Shares held
- 71.4M
- +11.5M (+19.2%) vs. Q3 2022
- Total value
- $1.82B
- +$377.2M (+26.2%) vs. Q3 2022
- New holders
- 32
- 65 more added
- Sold out
- 10
- 41 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $2.36B |
| Q1 2026 | 247 | $2.32B |
| Q4 2025 | 230 | $2.10B |
| Q3 2025 | 227 | $1.56B |
| Q2 2025 | 217 | $952.6M |
| Q1 2025 | 219 | $1.24B |
| Q4 2024 | 216 | $1.30B |
| Q3 2024 | 210 | $1.71B |
| Q2 2024 | 196 | $1.79B |
| Q1 2024 | 189 | $2.15B |
| Q4 2023 | 177 | $1.92B |
| Q3 2023 | 175 | $1.03B |
| Q2 2023 | 166 | $1.48B |
| Q1 2023 | 163 | $1.54B |
| Q4 2022 | 160 | $1.82B |
| Q3 2022 | 139 | $1.44B |
| Q2 2022 | 121 | $1.06B |
| Q1 2022 | 136 | $948.4M |
| Q4 2021 | 132 | $1.15B |
| Q3 2021 | 123 | $938.0M |
| Q2 2021 | 115 | $861.9M |
| Q1 2021 | 130 | $1.08B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Syndax Pharmaceuticals Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tekla Capital Management LLC | 117,717 | $3.00M | 0.11% | +117,717 | New |
| Swiss National Bank | 129,400 | $3.29M | 0.00% | +16,100+14.2% | Added |
| Prudential Financial Inc | 139,675 | $3.55M | 0.01% | +34,005+32.2% | Added |
| Nuveen Asset Management, LLC | 144,862 | $3.69M | 0.00% | −21,015−12.7% | Reduced |
| Morgan Stanley | 149,369 | $3.80M | 0.00% | −9,202−5.8% | Reduced |
| Ghost Tree Capital, LLC | 150,000 | $3.82M | 1.63% | −50,000−25.0% | Reduced |
| D. E. Shaw & Co., Inc. | 160,435 | $4.08M | 0.01% | +32,407+25.3% | Added |
| Norges Bank | 169,100 | $4.30M | 0.00% | −19,100−10.1% | Reduced |
| UBS Group AG | 172,785 | $4.40M | 0.00% | −112,747−39.5% | Reduced |
| Panagora Asset Management Inc | 179,085 | $4.56M | 0.03% | +110,282+160.3% | Added |
| Macquarie Group Ltd | 180,000 | $4.58M | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 192,483 | $4.90M | 0.00% | +3,289+1.7% | Added |
| Soleus Capital Management, L.P. | 220,000 | $5.60M | 0.80% | +220,000 | New |
| Ensign Peak Advisors, Inc | 235,370 | $5.99M | 0.01% | +24,002+11.4% | Added |
| Rafferty Asset Management, LLC | 264,762 | $6.74M | 0.06% | +118,380+80.9% | Added |
| Citigroup Inc | 265,933 | $6.77M | 0.01% | −265,053−49.9% | Reduced |
| Bank of America Corp | 267,712 | $6.81M | 0.00% | −34,416−11.4% | Reduced |
| Two Sigma Advisers, LP | 317,852 | $8.09M | 0.02% | −53,900−14.5% | Reduced |
| Acuta Capital Partners, LLC | 324,614 | $8.26M | 5.08% | 00.0% | Unchanged |
| Walleye Capital LLC | 331,551 | $8.44M | 0.18% | +331,551 | New |
| Lord, Abbett & Co. LLC | 335,996 | $8.55M | 0.03% | +1,033+0.3% | Added |
| Caas Capital Management LP | 344,168 | $8.76M | 1.68% | +344,168 | New |
| Ghisallo Capital Management LLC | 350,000 | $8.91M | 1.59% | +350,000 | New |
| Iron Triangle Partners LP | 370,294 | $9.42M | 1.69% | +370,294 | New |
| Goldman Sachs Group Inc | 438,243 | $11.2M | 0.00% | −129,838−22.9% | Reduced |
| DAFNA Capital Management LLC | 447,073 | $11.4M | 3.20% | +91,586+25.8% | Added |
| Charles Schwab Investment Management Inc | 448,741 | $11.4M | 0.00% | +63,620+16.5% | Added |
| Deep Track Capital, LP | 500,000 | $12.7M | 0.55% | +500,000 | New |
| JPMorgan Chase & Co | 538,126 | $13.7M | 0.00% | −78,125−12.7% | Reduced |
| Northern Trust Corp | 549,091 | $14.0M | 0.00% | +45,129+9.0% | Added |
| 683 Capital Management, LLC | 570,000 | $14.5M | 1.31% | −560,000−49.6% | Reduced |
| Palo Alto Investors LP | 612,600 | $15.6M | 1.33% | 00.0% | Unchanged |
| Commodore Capital LP | 688,445 | $17.5M | 2.64% | −49,665−6.7% | Reduced |
| Sofinnova Investments, Inc. | 703,074 | $17.9M | 1.09% | +178,072+33.9% | Added |
| Sphera Funds Management Ltd. | 710,561 | $18.1M | 5.68% | −112,135−13.6% | Reduced |
| Foresite Capital Management IV, LLC | 875,000 | $22.3M | 9.51% | +185,000+26.8% | Added |
| Point72 Asset Management, L.P. | 923,400 | $23.5M | 0.09% | +923,400 | New |
| Adage Capital Partners GP, L.L.C. | 940,000 | $23.9M | 0.06% | −310,000−24.8% | Reduced |
| Barclays PLC | 963,336 | $24.5M | 0.02% | +687,577+249.3% | Added |
| Nantahala Capital Management, LLC | 975,705 | $24.8M | 2.24% | −399,723−29.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,002,886 | $25.5M | 0.02% | +79,660+8.6% | Added |
| Aisling Capital Management LP | 1,025,000 | $26.1M | 17.22% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,101,029 | $28.0M | 0.00% | +132,900+13.7% | Added |
| Braidwell LP | 1,242,802 | $31.6M | 1.06% | +1,242,802 | New |
| Dimensional Fund Advisors LP | 1,266,129 | $32.2M | 0.01% | +143,677+12.8% | Added |
| BVF Inc | 1,451,197 | $36.9M | 1.56% | −346,888−19.3% | Reduced |
| Eversept Partners, LP | 1,620,713 | $41.2M | 3.92% | +409,279+33.8% | Added |
| Citadel Advisors LLC | 1,627,853 | $41.4M | 0.05% | +261,082+19.1% | Added |
| PFM Health Sciences, LP | 1,814,634 | $46.2M | 1.95% | +525,561+40.8% | Added |
| Paradigm Biocapital Advisors LP | 1,954,512 | $49.7M | 5.84% | +869,370+80.1% | Added |
| OrbiMed Advisors LLC | 2,006,500 | $51.1M | 0.98% | 00.0% | Unchanged |
| Jennison Associates LLC | 2,302,246 | $58.6M | 0.06% | +652,451+39.5% | Added |
| Kynam Capital Management, LP | 2,561,187 | $65.2M | 10.00% | +288,272+12.7% | Added |
| Avoro Capital Advisors LLC | 2,650,000 | $67.4M | 1.01% | +427,778+19.3% | Added |
| Vanguard Group Inc | 3,363,450 | $85.6M | 0.00% | +561,151+20.0% | Added |
| State Street Corp | 3,648,463 | $92.9M | 0.01% | +1,031,026+39.4% | Added |
| Frazier Life Sciences Management, L.P. | 3,708,838 | $94.4M | 5.87% | +296,000+8.7% | Added |
| BlackRock Inc. | 4,352,032 | $110.8M | 0.00% | +212,415+5.1% | Added |
| Avidity Partners Management LP | 5,861,000 | $149.2M | 3.49% | +274,100+4.9% | Added |
| Wellington Management Group LLP | 7,983,442 | $203.2M | 0.04% | +3,596,002+82.0% | Added |
| Woodline Partners LP | 0 | $0 | 0.00% | −789,273−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −276,731−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −110,729−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −58,466−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −25,576−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −21,563−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −10,737−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −1,234−100.0% | Sold out |
| Quent Capital, LLC | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |